Functional Prognosis in Patients With Ischemic Stroke According to the Therapeutic Strategy Used (PARADISE)
Prognosis After Revascularization Therapy in the Dijon Ischemic Stroke Evaluation Study
The current management of ischemic stroke is based on different strategies that may be combined: intravenous thrombolysis in a stroke ICU, intravenous thrombolysis in a telemedicine procedure, endovascular thrombectomy. Given this now rich therapeutic arsenal, it seems necessary to evaluate practices in local care in the field and the impact of these on the prognosis of ischemic stroke victims. The aim of this observational study is to compare these different care practices without interfering with the choice of strategy.
A blood sample will also be taken at different times to study the value of growth differentiation factors (GDF) 8, 11 and 15, and Brain-derived Neurotrophic Factor as prognostic biomarkers
研究概览
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
-
Dijon、法国、21079
- CHU Dijon Bourgogne
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Patients with symptomatic ischemic stroke defined according to WHO criteria and treated by intravenous thrombolysis at the stroke ICU at Dijon CHU, intravenous thrombolysis by telemedicine with subsequent transfer to the Dijon stroke ICU, and/or endovascular thrombectomy at Dijon CHU)
- Patients aged over 18 years.
- Patients who have provided written informed consent to take part in the study.
Exclusion Criteria:
- Patients who refuse to take part in the study.
- Subjects in custody.
- Patients (or a person of trust) who cannot be contacted by telephone during the follow-up.
学习计划
研究是如何设计的？
设计细节
- 主要用途：预防
- 分配：不适用
- 介入模型：单组作业
- 屏蔽：无（打开标签）
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：Ischemic stroke patients
|
研究衡量的是什么？
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Rate of handicap
大体时间：6 months
|
6 months
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
Serum levels of biomarkers of stress
大体时间：Changes compared with baseline levels at Day 1, Day 3, Day 7
|
Changes compared with baseline levels at Day 1, Day 3, Day 7
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.
prise de sang的临床试验
-
Medwave Estudios LimitadaAsociación Chilena de Seguridad未知
-
University of Wisconsin, MadisonAgency for Healthcare Research and Quality (AHRQ)完全的